According to Khan and Alkon (who showed Alzheimer’s disease-specific changes in the Erk1/Erk2 phosphorylation ratio), AD-specific changes were found in the p-Erk1/Erk2 ratio. This evidence concerns the gene MAPK3 and Alzheimer disease.